))
Long COVID: Current research on risk factors, pathophysiology, and emerging treatments
Manage episode 454125742 series 3382357
Sisällön tarjoaa healthedaustralia. healthedaustralia tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
- Why Long COVID is a large and growing concern as new insights emerge at great speed
- Understand the proposed mechanisms driving Long COVID, including the two main mechanisms of persistent infection and the role of toxic fibrin induced vascular damage
- How to clinically assess Long COVID in patients
- Role of antivirals in reducing the duration, severity and potentially preventing the impact of Long COVID
- Three hierarchical drivers of preventing the impact of Long COVID, how can this messaging help your patient
- What should be your tool kit of prevention, when explaining Long COVID to your patients, especially the vulnerable ones
- Risk of long lasting viraemia in the body causing future chronic conditions
- Use of CoRiCal, a COVID calculator (including Long COVID); beneficial as a tool in your practice
Host: Dr David Lim | Total Time: 54 mins
Experts: Prof Brendan Crabb, Infectious Disease Researcher
A/Prof John Litt AM, Public Health Physician
Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT
Click here to register for the next one
See omnystudio.com/listener for privacy information.
100 jaksoa
Jaa
